1998 - Bachelor's Degree: Xiangya Medical College, Central South University
2004 - Master's Degree: Harbin Medical University
2009 - PhD: Tongji University
Visiting Scholar at Dana-Farber Cancer Institute, Harvard Medical School (2012-2014)
Visiting Scholar at Molecular Biotechnology Center, University of Turin, Italy (2022-2023)
2004 - Present: Professor at School of Life Sciences and Technology, Tongji University
Research
Tumor heterogeneity and precision combined medication research Cancer novel biomarkers research
ExosomePurity: tumour purity deconvolution in serum exosomes based on miRNA signatures, Wu T, Dai Y, Xu Y, Zheng J, Chen S, Zhang Y, Tian P, Zheng X, Wang H, 2023
Identification and characterization of virus-encoded circular RNAs in host cells, Chen S, Zheng J, Zhang B, Tang X, Cun Y, Wu T, Xu Y, Ma T, Cheng J, Yu Z, Wang H, 2022
Evolution of gene expression signature in mammary gland stem cells from neonatal to old mice, Huang X, Xu Y, Qian L, Zhao Q, Liu P, Lü J, Guo Y, Ma W, Wang G, Li S, Luo A, Yang X, Wang H, Yu Z, 2022
Therapeutic Response-Based Reclassification of Multiple Tumor Subtypes Reveals Intrinsic Molecular Concordance of Therapy Across Histologically Disparate Cancers, Xu Y, Zheng J, Cai Z, Li W, Köhler J, Dai Y, Cheng X, Wu T, Zhang F, Wang H, 2021
Pharmaco-omics data sheds light on therapy-oriented prospects of precision medicine, Zheng J, Wang H, 2021
Unbiased RNA-Seq-driven identification and validation of reference genes for quantitative RT-PCR analyses of pooled cancer exosomes, Dai Y, Cao Y, Köhler J, Lu A, Xu S, Wang H, 2021
Fcirc: A comprehensive pipeline for the exploration of fusion linear and circular RNAs, Cai Z, Xue H, Xu Y, Köhler J, Cheng X, Dai Y, Zheng J, Wang H, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas, Esteban-Burgos L, Wang H, Nieto P, Zheng J, Blanco-Aparicio C, Varela C, Gómez-López G, Fernández-García F, Sanclemente M, Guerra C, Drosten M, Galán J, Caleiras E, Martínez-Torrecuadrada J, Fajas L, Peng SB, Santamaría D, Musteanu M, Barbacid M, 2020
Cancer stem cell property and gene signature in bone-metastatic Breast Cancer cells, Luo A, Xu Y, Li S, Bao J, Lü J, Ding N, Zhao Q, Fu Y, Liu F, Cho WC, Wei X, Wang H, Yu Z, 2020
Drosophila as a model for studying cystic fibrosis pathophysiology of the gastrointestinal system, Kim K, Lane EA, Saftien A, Wang H, Xu Y, Wirtz-Peitz F, Perrimon N, 2020
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer, Wang H, Lv Q, Xu Y, Cai Z, Zheng J, Cheng X, Dai Y, Jänne P, Ambrogio C, Köhler J, 2019
Longevity Effect of Liuwei Dihuang in Both Caenorhabditis Elegans and Aged Mice, Chen W, Wang J, Shi J, Yang X, Yang P, Wang N, Yang S, Xie T, Yang H, Zhang M, Wang H, Fei J, 2019
Hunt for the tipping point during endocrine resistance process in breast cancer by dynamic network biomarkers, Liu R, Wang J, Ukai M, Sewon K, Chen P, Suzuki Y, Wang H, Aihara K, Okada-Hatakeyama M, Chen L, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS, Ambrogio C, Köhler J, Zhou ZW, Wang H, Paranal R, Li J, Capelletti M, Caffarra C, Li S, Lv Q, Gondi S, Hunter JC, Lu J, Chiarle R, Santamaría D, Westover KD, Jänne PA, 2018
New strategies for targeting drug combinations to overcome mutation-driven drug resistance, Wang L, Wang H, Song D, Xu M, Liebmen M, 2017
An integrative pharmacogenomic approach identifies two-drug combination therapies for personalized cancer medicine, Liu Y, Fei T, Zheng X, Brown M, Zhang P, Liu X, Wang H, 2016
Post-transcriptional and translational regulation modulates gene co-expression behavior in more synchronized pace to carry out molecular function in the cell, Wang J, Lv Q, Li X, Liu Y, Liu K, Wang H, 2016
Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model, Zhang N, Wang H, Fang Y, Wang J, Zheng X, Liu X, 2015
Towards pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway, Wang H, Zheng X, Fei T, Wang J, Li X, Liu Y, Zhang F, 2015
A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer, Wang H, Meyer C, Fei T, Wang G, Zhang F, Liu X, 2013
Systematic investigation of global coordination among mRNA and protein in cellular society, Wang H, Wang Q, Shen B, Li X, 2010
Towards patterns tree of gene coexpression in eukaryotic species, Wang H, Wang Q, Li X, Shen B, Ding M, Shen Z, 2008
